Literature DB >> 12607580

Palliative treatment of unresectable bile duct cancer: which stent? which approach?

David C Madoff1, Michael J Wallace.   

Abstract

Nonsurgical options for the palliative treatment of unresectable bile duct cancer are discussed. Despite all of the available approaches, the disease remains uniformly fatal. The goal of managing unresectable bile duct cancer is to treat the symptoms that still contribute to significant morbidity and mortality. Further development of new treatment strategies and modalities is needed to improve the quality of life and survival of patients with this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12607580     DOI: 10.1016/s1055-3207(02)00037-6

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  2 in total

1.  Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness.

Authors:  P Katsinelos; D Paikos; J Kountouras; G Chatzimavroudis; G Paroutoglou; I Moschos; A Gatopoulou; A Beltsis; C Zavos; B Papaziogas
Journal:  Surg Endosc       Date:  2006-08-07       Impact factor: 4.584

2.  Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas.

Authors:  Toshio Tsuyuguchi; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Masato Nagino; Satoshi Kondo; Junji Furuse; Hiroya Saito; Masafumi Suyama; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.